close

    BSE : 532296

    NSE : GLENMARK

    Sector :Health care

    ISIN Code : INE935A01035

    NSE

    591.40
    -16.00 (-2.63%)

    00:00 AM,26th May 2023
    Open
    606.20
    High
    609.70
    Low
    587.00

    BSE

    591.55
    -15.90 (-2.62%)

    00:00 AM,26th May 2023
    Open
    601.05
    High
    608.00
    Low
    587.00

    Glenmark Pharmaceuticals Ltd

    • NSE
    • BSE
    • 1D
    • 5D
    • 1M
    • 6M
    • 1Y
    • 2Y
    • 5Y
    • MAX

    Statistics Overview

    M.cap

    16693.54

    Volume

    81165

    52-Week High

    630.00

    52-Week Low

    348.90

    EPS-TTM

    591.55

    P/E Ratio

    10.55

    P/B Ratio

    0.93

    Book Value Share

    633.57

    Face Value

    1

    Dividend Date

    12 Sep 2022

    Dividend Yield

    0.42

    F & O Quote

    No Data Found

    Share Price Returns

    Stock Strength

    Today's Low/High

    587.00

    Stock

    608.00

    Week Low/High

    581.20

    Stock

    630.00

    Month Low/High

    516.65

    Stock

    630.00

    YEAR Low/High

    348.90

    Stock

    630.00

    All TIME Low/High

    1.89

    Stock

    1262.00

    Financials

    • Graph
    • Table

    Bulk/ Block

    • ALL
    • NSE
    • BSE
    • ALL
    • BUY
    • SELL
    DateClient NameExchangeTransactionQuantityPrice
    25-10-2022ISHARES CORE EMERGING MARKETS MAURITIUS COBSESELL302621397.90
    25-10-2022ISHARES CORE MSCI EMERGING MARKETS ETFBSEBUY302621397.90
    25-10-2022ISHARES INDIA SC MAURITIUS COMPANYBSESELL39265397.90
    25-10-2022ISHARES MSCI INDIA SMALL-CAP ETFBSEBUY39265397.90
    17-10-2022ISHARES CORE EMERGING MARKETS MAURITIUS COBSESELL302331390.85
    17-10-2022ISHARES CORE MSCI EMERGING MARKETS ETFBSEBUY302331390.85
    17-10-2022ISHARES INDIA SC MAURITIUS COMPANYBSESELL39226390.85
    17-10-2022ISHARES MSCI INDIA SMALL-CAP ETFBSEBUY39226390.85
    11-10-2022ISHARES CORE EMERGING MARKETS MAURITIUS COBSESELL294302393.10
    11-10-2022ISHARES CORE MSCI EMERGING MARKETS ETFBSEBUY294302393.10

    Peer Group Comparison

    • Graph
    • Table
    DatePrice (X)

    Shareholding Pattern

    • Graph
    • Table
    CategoryShare(%)
    Promoter46.65
    Financial Institutions Banks0.20
    Foreign Institutional Investors22.46
    Insurance Companies4.41
    Mutual Funds Uti5.43
    Indian Public16.90
    Custodians0.00
    Other3.55

    Corporate Action

    No record

    Announcement DatePurposeFromToRemarks

    Price History

    Search for Price History

    No Data Found
    DateOpenHighLowCloseSharesTrades

    Load more

    Company Info

    Company Information

    Chairman & Managing Director : Glenn Saldanha

    Non-Exec. & Independent Dir. : Sridhar Gorthi

    Director (Corporate Affairs) : Cheryl Pinto

    Non-Exec. & Independent Dir. : D R Mehta

    Non-Exec & Non-Independent Dir : B E Saldanha

    Non-Exec. & Independent Dir. : Rajesh Desai.

    Non-Exec. & Independent Dir. : Brian W Tempest

    Non-Exec. & Independent Dir. : Bernard Munos

    Company Sec. & Compli. Officer : Harish Kuber

    Executive Director & CFO : V S Mani

    Non-Exec. & Independent Dir. : Sona Saira Ramasastry

    Non-Exec. & Independent Dir. : Dipankar Bhattacharjee

    Registered Office: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road,Mumbai,Maharashtra-400026 Ph: 91-22-40189999

    Email:complianceofficer@glenmarkpharma.com

    URL:http://www.glenmarkpharma.com